ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

ClinicalTrials.gov ID: NCT07215234

Public ClinicalTrials.gov record NCT07215234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1/2, Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Study identification

NCT ID
NCT07215234
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
104 participants

Conditions and interventions

Interventions

  • SAR446597 Drug
  • Sham Comparator Drug

Drug

Eligibility (public fields only)

Age range
60 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 8, 2025
Primary completion
Oct 12, 2027
Completion
Jul 21, 2032
Last update posted
Apr 20, 2026

2025 – 2032

United States locations

U.S. sites
14
U.S. states
7
U.S. cities
13
Facility City State ZIP Site status
Associated Retina Consultants - Peoria- Site Number : 8400011 Peoria Arizona 85381 Recruiting
Retina Macula Institute of Arizona- Site Number : 8400028 Scottsdale Arizona 85255 Recruiting
Vitreo Retinal Associates - Gainesville- Site Number : 8400004 Gainesville Florida 32607 Recruiting
Retina Vitreous Associates of Florida - St. Petersburg- Site Number : 8400002 St. Petersburg Florida 33711 Recruiting
University Retina - Lemont- Site Number : 8400005 Lemont Illinois 60439 Recruiting
The Retina Group of Washington - Chevy Chase- Site Number : 8400009 Chevy Chase Maryland 20815 Recruiting
Cumberland Valley Retina Consultants - Hagerstown- Site Number : 8400003 Hagerstown Maryland 21740 Recruiting
Oregon Retina- Site Number : 8400017 Eugene Oregon 97401 Recruiting
Mid Atlantic Retina - Bethlehem- Site Number : 8400031 Bethlehem Pennsylvania 18017-9412 Recruiting
Austin Clinical Research - Austin - Anderson Mill Road- Site Number : 8400007 Austin Texas 78750 Recruiting
Retina Consultants of Texas - Bellaire- Site Number : 8400019 Bellaire Texas 77401 Recruiting
Retina Foundation of the Southwest- Site Number : 8400001 Dallas Texas 75231 Recruiting
Texas Retina Associates - Dallas- Site Number : 8400006 Dallas Texas 75231 Recruiting
Retinal Consultants of Texas - San Antonio- Site Number : 8400012 San Antonio Texas 78240 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07215234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07215234 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →